|
1
|
Li D, Fareh S, Leung TK and Nattel S:
Promotion of atrial fibrillation by heart failure in dogs: Atrial
remodeling of a different sort. Circulation. 100:87–95. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Nattel S: How does fibrosis promote atrial
fibrillation persistence: In silico findings, clinical observations
and experimental data. Cardiovasc Res. 110:295–297. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Polyakova V, Miyagawa S, Szalay Z, Risteli
J and Kostin S: Atrial extracellular matrix remodelling in patients
with atrial fibrillation. J Cell Mol Med. 12:189–208. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yue L, Xie J and Nattel S: Molecular
determinants of cardiac fibroblast electrical function and
therapeutic implications for atrial fibrillation. Cardiovasc Res.
89:744–753. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Miragoli M, Salvarani N and Rohr S:
Myofibroblasts induce ectopic activity in cardiac tissue. Circ Res.
101:755–758. 2007.PubMed/NCBI
|
|
6
|
Conway DS, Buggins P, Hughes E and Lip GY:
Prognostic significance of raised plasma levels of interleukin-6
and C-reactive protein in atrial fibrillation. Am Heart J.
148:462–466. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Guo Y, Lip GY and Apostolakis S:
Inflammation in atrial fibrillation. J Am Coll Cardiol.
60:2263–2270. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Rao F, Deng CY, Wu SL, Xiao DZ, Yu XY,
Kuang SJ, Lin QX and Shan ZX: Involvement of Src in L-type
Ca2+ channel depression induced by macrophage migration
inhibitory factor in atrial myocytes. J Mol Cell Cardiol.
47:586–594. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Deng H, Xue YM, Zhan XZ, Liao HT, Guo HM
and Wu SL: Role of tumor necrosis factor-alpha in the pathogenesis
of atrial fibrillation. Chin Med J (Engl). 124:1976–1982.
2011.PubMed/NCBI
|
|
10
|
Yamashita T, Sekiguchi A, Suzuki S,
Ohtsuka T, Sagara K, Tanabe H, Kunihara T, Sawada H and Aizawa T:
Enlargement of the left atrium is associated with increased
infiltration of immune cells in patients with atrial fibrillation
who had undergone surgery. J Arrhythm. 31:78–82. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sonmez O, Ertem FU, Vatankulu MA, Erdogan
E, Tasal A, Kucukbuzcu S and Goktekin O: Novel fibro-inflammation
markers in assessing left atrial remodeling in non-valvular atrial
fibrillation. Med Sci Monit. 20:463–470. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Canpolat U, Aytemir K, Hazirolan T, Özer N
and Oto A: Serum YKL-40 as a marker of left atrial fibrosis
assessed by delayed enhancement MRI in lone atrial fibrillation.
Pacing Clin Electrophysiol. 38:1386–1395. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Rao F, Deng CY, Wu SL, Xiao DZ, Huang W,
Deng H, Kuang SJ, Lin QX, Shan ZX, Liu XY, et al: Mechanism of
macrophage migration inhibitory factor-induced decrease of T-type
Ca(2+) channel current in atrium-derived cells. Exp Physiol.
98:172–182. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wang WK, Wang B, Lu QH, Zhang W, Qin WD,
Liu XJ, Liu XQ, An FS, Zhang Y and Zhang MX: Inhibition of
high-mobility group box 1 improves myocardial fibrosis and
dysfunction in diabetic cardiomyopathy. Int J Cardiol. 172:202–212.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Barth AS, Merk S, Arnoldi E, Zwermann L,
Kloos P, Gebauer M, Steinmeyer K, Bleich M, Kääb S, Hinterseer M,
et al: Reprogramming of the human atrial transcriptome in permanent
atrial fibrillation: Expression of a ventricular-like genomic
signature. Circ Res. 96:1022–1029. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Mewhort HE, Lipon BD, Svystonyuk DA, Teng
G, Guzzardi DG, Silva C, Yong VW and Fedak PW: Monocytes increase
human cardiac myofibroblast-mediated extracellular matrix
remodeling through TGF-β1. Am J Physiol Heart Circ Physiol.
310:H716–H724. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Fu XX, Zhao N, Dong Q, Du LL, Chen XJ, Wu
QF, Cheng X, Du YM and Liao YH: Interleukin-17A contributes to the
development of post-operative atrial fibrillation by regulating
inflammation and fibrosis in rats with sterile pericarditis. Int J
Mol Med. 36:83–92. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kong YZ, Yu X, Tang JJ, Ouyang X, Huang
XR, Fingerle-Rowson G, Bacher M, Scher LA, Bucala R and Lan HY:
Macrophage migration inhibitory factor induces MMP-9 expression:
Implications for destabilization of human atherosclerotic plaques.
Atherosclerosis. 178:207–215. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Schmeisser A, Marquetant R, Illmer T,
Graffy C, Garlichs CD, Bockler D, Menschikowski D, Braun-Dullaeus
R, Daniel WG and Strasser RH: The expression of macrophage
migration inhibitory factor 1alpha (MIF 1alpha) in human
atherosclerotic plaques is induced by different proatherogenic
stimuli and associated with plaque instability. Atherosclerosis.
178:83–94. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Matsui Y, Okamoto H, Jia N, Akino M, Uede
T, Kitabatake A and Nishihira J: Blockade of macrophage migration
inhibitory factor ameliorates experimental autoimmune myocarditis.
J Mol Cell Cardiol. 37:557–566. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Willis MS, Carlson DL, Dimaio JM, White
MD, White DJ, Adams GA IV, Horton JW and Giroir BP: Macrophage
migration inhibitory factor mediates late cardiac dysfunction after
burn injury. Am J Physiol Heart Circ Physiol. 288:H795–H804. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Cary LA, Klinghoffer RA, Sachsenmaier C
and Cooper JA: SRC catalytic but not scaffolding function is needed
for integrin-regulated tyrosine phosphorylation, cell migration and
cell spreading. Mol Cell Biol. 22:2427–2440. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chen Q, Zhou Z, Shan L, Zeng H, Hua Y and
Cai Z: The importance of Src signaling in sarcoma. Oncol Lett.
10:17–22. 2015.PubMed/NCBI
|
|
24
|
Cai T, Kuang Y, Zhang C, Zhang Z, Chen L,
Li B, Li Y, Wang Y, Yang H, Han Q and Zhu Y: Glucose-6-phosphate
dehydrogenase and NADPH oxidase 4 control STAT3 activity in
melanoma cells through a pathway involving reactive oxygen species,
c-SRC and SHP2. Am J Cancer Res. 5:1610–1620. 2015.PubMed/NCBI
|
|
25
|
Lin CC, Pan CS, Wang CY, Liu SW, Hsiao LD
and Yang CM: Tumor necrosis factor-alpha induces VCAM-1-mediated
inflammation via c-Src-dependent transactivation of EGF receptors
in human cardiac fibroblasts. J Biomed Sci. 22:532015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Boekhoudt GH, McGrath AG, Swisher JF and
Feldman GM: Immune complexes suppress IFN-γ-induced responses in
monocytes by activating discrete members of the SRC kinase family.
J Immunol. 194:983–989. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Burstein B, Libby E, Calderone A and
Nattel S: Differential behaviors of atrial versus ventricular
fibroblasts: A potential role for platelet-derived growth factor in
atrial-ventricular remodeling differences. Circulation.
117:1630–1641. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Yeh YH, Kuo CT, Chang GJ, Qi XY, Nattel S
and Chen WJ: Nicotinamide adenine dinucleotide phosphate oxidase 4
mediates the differential responsiveness of atrial versus
ventricular fibroblasts to transforming growth factor-β. Circ
Arrhythm Electrophysiol. 6:790–798. 2013. View Article : Google Scholar : PubMed/NCBI
|
